Page 1903 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

1330 Index

Anaphylaxis, 901, 1283 Anti-interleukin-2 receptor antibodies, 1090 Arenaviridae, 738–740
drug-induced, 1283 Antimalarial treatment, 726–727, 726t Argatroban, 329
laboratory in diagnosis of, Antimicrobial classes, 545–549, 548t Argentine hemorrhagic fever, 739
1276–1277, 1276t Antimicrobial impregnated catheters, 183 Arginine, 138
Ancillary therapies for acute right heart Antimicrobial stewardship, 550 Arrhythmia evaluation, 199–200, 200f
syndromes, 317 Antimicrobial therapy, 523, 544–551 Arrow, Kenneth, 38
Andes virus, 742 classes, 545–552, 548t Arterial blood gases, pulse oximetry
Anemia for infectious diarrhea, 708 and, 498
defined, 842 pharmacokinetics and pharmacodynamics Arterial catheters and pressure transducers, 25
pathophysiology of, in critical illness, 842 in critically ill patients, Arterial graft infections, 598
physiologic response to, 842 544–545, 544f Arterial hypoxemia, 1143
https://kat.cr/user/tahir99/
sickle cell, 903 renal replacement therapy, 549–550 Arterial pulse contour analysis and cardiac
thrombocytopenia and, 870, 870t stewardship, 550 output, 247–248, 247f
treatment of, 728 for tetanus, 732 Arterial pulse oximetry, 242–243, 243f
Aneurysm(s) Antinuclear antibodies, 1248–1249 Arterial puncture/bleeding, 183–185
intracranial mycotic, 687 Antioxidant vitamins and trace minerals, 139 Arterial thrombolysis, leg pain in, 218
mycotic, 597 Antiplatelet therapy, 302–303 Arthritis, rheumatoid, 409, 826, 1244–1245
subarachnoid hemorrhage due to ruptured Antipyretic drugs for fever, 561 Artificial feeding and hydration, 127–128
intracranial, 775–778 Antiretroviral therapy (ART), 625 Ascites, spontaneous bacterial peritonitis and,
Angina Antiseizure prophylaxis, 1128–1129 1029–1030
Ludwig, 406, 679, 680, 681 Antitoxin therapy, for tetanus, 731–732 Aseptic necrosis, 1090
management of, 297–298 Antiviral therapy, for influenza, 716 A Severity Characterization of Trauma
refractory, 298 Aortic branch compromise, 365 (ASCOT), 89
stable, 294 Aortic branch occlusion, signs and symptoms Aspiration, 1052
unstable, 294 of, 359–360, 361f in pregnancy, 1266
Angiodysplasia, 1018, 1020 Aortic dissection, 356–368 reducing risk of, 136–137
Angioedema, 407, 409–410, 1283 classification of, 357 Aspirin, 297, 300
acquired, 409–410 clinical picture, 357, 358f, 359–360, 359f Assessment of severity of illness, 83–96
hereditary, 409 follow-up, 368 clinical, administrative, and management
Angiotensin converting enzyme (ACE) intramural hematoma, 357 uses of scoring systems, in
inhibitors, 298, 302 investigations and diagnosis of, 360–368 randomized controlled trials and
Anion gap, 1200–1201, 1201t diagnostic imaging, 360–362, 360f, other clinical research, 90
acid-base balance and, 970–971 361f, 362f development of scoring systems,
Anoxia, 842 laboratory, 360 84–85, 85f
Anrep effect, 309 natural history, 362 ethical issues in, 92–93, 93f
Anterolateral thoracotomy, 1157 treatment of, 363 purposes of scoring systems, 83–84, 84t
Anthracyclines, 896 pathogenesis, 356–357, 356f recommendations for clinical use, 96
Anthrax, 745, 746t pharmacologic control of blood pressure, severity-of-illness scoring systems in
Antiarrhythmics, 316 363–365 clinical use, 85, 86–87t
in drug therapy, 279–280, 280ft, 302 acute management of, 363–364, 363t for administrative purposes, 90–91
Antibiotic resistance chronic management of, 364 to assess individual patient prognosis and
epidemiology of, 27, 27t definitive management of, 364–365, to guide care, 91–92, 92f
in intensive-care unit, 27 365f to assess intensive care unit
preventing results, morbidity, 367 performance, 91
hand hygiene, 28 surgical intervention, 365–367 comparison of clinical assessment
surveillance, 27–28 type A, 365–366, 365f, 366f with, 89
use and control, 27–28 type B, 366, 366f comparison of difference, 89
Antibiotics Aortic intramural hematoma, 357 customization of, for specific diseases, 89
percutaneous abscess drainage and, 210 Aortic regurgitation, 347–348 dynamic severity of illness, 88–89
in preventing antibiotic resistance in clinical presentation of, 347 established at admission, 88
intensive-care unit, 27 diagnostic evaluation of, 347–348 specific for trauma patients, 89–90, 90t
role of prophylactic in acute pancreatitis, etiology of, 347, 347f sources of error and bias in scoring systems
1034, 1034f management of, 348 imprecise principal diagnosis of, 94, 94f
for sepsis, 569–570 pathophysiology of, 347 inaccuracy of scoring systems for certain
Antibodies to cyclic citrullinated Aortic rupture, 1159–1160, 1159f types of intensive-care units or
peptide, 1249 Aortic stenosis, 344–347 different geographic regions, 94–95
Anticancer therapies, review of, clinical presentation, 345 lead-time, 94
891–892, 892t diagnostic evaluation, 345, 345t propensity scoring systems and case
Anticardiolipin antibodies, 1249–1250 etiology, 344, 344f matching to simulate randomized
Anticoagulant-induced dermatoses, natural history, 344 controlled trials, 95–96
1285–1286, 1285f, 1286f pathophysiology, 344 related to poor calibration, 93–94, 93f
Anticoagulants, 301, 301t, 304 Aortic valve operations, 1069 related to selection of variables and
pharmacologic, 854–855 Aortic valvular stenosis, 274 collection of data, 93
Anticoagulation, 327–329, 940–941 Aortoenteric fistula, 1021 severity-of-illness scoring systems
for ECMO, 474–475 Apoptosis, 555 for systems for specific disease
Antidiuretic hormone (ADH), 944, 1046 gene expression and, 555 categories, 94
Antifactor Xa activity, 848 ARDS Network, 447 Assistive technologies, 165

Index.indd 1330 23-01-2015 15:33:50